Fed. Circ. Affirms Cephalon Win In Generic Fentora IP Suit

Law360, New York (December 8, 2011, 2:46 PM EST) -- The Federal Circuit on Thursday upheld a Delaware court's ruling that Watson Pharmaceuticals Inc.’s proposed generic version of Fentora infringes Cephalon Inc.’s patent for the painkiller.

The appeals court affirmed the lower court's ruling in a nonprecedential, per curiam decision that did not offer an explanation for the decision.

U.S. District Judge Sue L. Robinson held in March that Watson's proposed generic version of Fentora, a drug used to treat breakthrough pain in cancer patients, infringed four claims of U.S. Patent Number 6,264,981, prompting Watson to...
To view the full article, register now.